Skip to content

Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance

Cytological Evaluation of Specimens Collected With the MAKO 7 Device in Pre Salpingo-Oophorectomy Subjects for Determination and/or Differentiation of Normal Versus Atypical Versus Malignant Cells

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02974842
Enrollment
50
Registered
2016-11-29
Start date
2016-11-02
Completion date
2017-09-27
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atypia Suspicious for Malignancy, BRCA1 Mutation, BRCA2 Mutation

Brief summary

This study evaluates the ability of the MAKO 7 device to collect various cells

Detailed description

Prospective, multi-center observational study to evaluate the ability of the MAKO 7 device to collect cells from the fallopian tubes for cytological evaluation for determination and/or differentiation of normal versus atypical versus malignant cells.

Interventions

DEVICEMAKO 7

Hysteroscopic cell sampling

Sponsors

nVision Medical
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subject is medically cleared for surgery 2. Subject is scheduled to undergo a salpingo-oophorectomy for a pelvic mass suspicious for malignancy or for BRCA1 or BRCA2 mutations 3. Subject must be 18 years of age 4. Subject must be able to provide informed consent

Exclusion criteria

1. Contraindication to hysteroscopy 2. Acute pelvic inflammatory disease 3. Active or recent lower pelvic infection 4. Pregnancy 5. Delivery or termination of a pregnancy in the past 6 weeks 6. Known tubal obstruction including tubal ligation 7. Invasive carcinoma of the cervix or endometrium 8. Intolerance of anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Concordance Between Cytological Findings From Fallopian Tubes to Surgical Histology Results.Up to 60 days post-operativelyCytological evaluations of samples collected from fallopian tubes were performed in a blinded fashion to histology findings from excised fallopian tubes and ovaries. Concordance was evaluated between cytology where collected samples were adequate and available histology.

Countries

United States

Participant flow

Recruitment details

Women scheduled for a salpingo-oophorectomy surgery due to suspicious adnexal mass or due to BRCA 1 or BRCA 2 mutation were recruited from three gynecologic oncology centers in the United States.

Pre-assignment details

This was a single arm study evaluating the feasibility of a novel hysteroscopic catheter to collect cytological samples.

Participants by arm

ArmCount
Eligible Participants With Hysteroscopic Attempt
Women scheduled for salpingo-oophorectomy who provided consent and met all inclusion criteria and none of the exclusion criteria.
42
Total42

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyScreen failures4
Overall StudyWithdrawal by Subject4

Baseline characteristics

CharacteristicEligible Participants With Hysteroscopic Attempt
Age, Continuous56.6 years
STANDARD_DEVIATION 15.7
Race/Ethnicity, Customized
Race/Ethnicity
Asian
6 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Caucasian
29 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Hispanic or Latino
3 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Native American or other Pacific Islander
1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Non-Hispanic or non-Latino
3 Participants
Reason for Surgery
BRCA 1 or BRCA 2 mutations
8 Participants
Reason for Surgery
Pelvic mass suspicious for malignancy
34 Participants
Region of Enrollment
United States
42 Participants
Sex: Female, Male
Female
42 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 42
other
Total, other adverse events
25 / 42
serious
Total, serious adverse events
0 / 42

Outcome results

Primary

Concordance Between Cytological Findings From Fallopian Tubes to Surgical Histology Results.

Cytological evaluations of samples collected from fallopian tubes were performed in a blinded fashion to histology findings from excised fallopian tubes and ovaries. Concordance was evaluated between cytology where collected samples were adequate and available histology.

Time frame: Up to 60 days post-operatively

Population: Fallopian tubes with adequate samples for cytological evaluation and available surgical histology results.

ArmMeasureCategoryValue (COUNT_OF_UNITS)
MAKO 7 GroupConcordance Between Cytological Findings From Fallopian Tubes to Surgical Histology Results.Discordant2 fallopian tubes
MAKO 7 GroupConcordance Between Cytological Findings From Fallopian Tubes to Surgical Histology Results.Concordant42 fallopian tubes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026